AAV Vector‐Mediated Modulation of Signaling Pathways in Neurological Disorders: Insights From Cellular, Animal, and Human Studies
- 20 July 2026
- journal article
- review article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 44 (7) , e70270
Abstract
One of the most efficient and promising viral vectors for the treatment of central nervous system (CNS) and peripheral nervous system (PNS)‐related diseases is adeno‐associated virals (AAVs), which in recent years, researchers have succeeded in substantially managing and mitigating these disorders by leveraging innovative therapeutic mechanisms at the cellular and molecular levels, which are widely utilized due to their favorable characteristics, including a robust safety profile, the ability to cross the blood‐brain barrier, and differential tropisms for distinct types of neuronal cells. Clinically, AAVs have high specificity and have therefore become a dynamic and useful tool for the gene therapy of a variety of neurological diseases. Many researchers around the world have been able to study a variety of neurological diseases in vitro cellular models, in vivo animal models, and human clinical studies using these vectors. Given these characteristics, the overall aim of the present review is to investigate the role of AAV vectors carrying coding and non‐coding RNAs in the treatment of a variety of neurological disorders, to study the relationship between these vectors and cellular signaling pathways, and to examine its clinical applications in various neurological diseases.Keywords
This publication has 220 references indexed in Scilit:
- Acetyl-CoA synthetase 2 alleviates brain injury following cardiac arrest by promoting autophagy in brain microvascular endothelial cellsCellular and Molecular Life Sciences, 2025
- Shh Protects the Injured Spinal Cord in Mice by Promoting the Proliferation and Inhibiting the Apoptosis of Nerve Cells via the Gli1–TGF–β1/ERK AxisCell Biochemistry and Function, 2024
- GluK2 Is a Target for Gene Therapy in Drug‐Resistant Temporal Lobe EpilepsyAnnals of Neurology, 2023
- EphA4 regulates white matter remyelination after ischemic stroke through Ephexin‐1/RhoA/ROCK signaling pathwayGlia, 2022
- Striatal Cholinergic Dysregulation after Neonatal Decrease in X‐Linked Dystonia Parkinsonism‐Related TAF1 IsoformsMovement Disorders, 2021
- Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesiaMovement Disorders, 2019
- Efficient Gene Suppression in Dorsal Root Ganglia and Spinal Cord Using Adeno-Associated Virus Vectors Encoding Short-Hairpin RNA2016
- Dopaminergic pathway reconstruction by Akt/Rheb‐induced axon regenerationAnnals of Neurology, 2011
- Gene Therapy for Neurological Diseases2009
- Immune responses to AAV in a phase I study for Canavan diseaseThe Journal of Gene Medicine, 2006